esophageal cancer Jun 28, 2022 QIMR Berghofer Licenses Esophageal Cancer Blood Biomarkers to Proteomics International May 16, 2022 Point Biopharma to Launch Phase I Study of FAP-Targeted Radiopharmaceutical in Canada Apr 5, 2022 Agilent Expands CE-IVD Mark for Companion Dx Tests Alongside BMS European Opdivo Approvals Mar 31, 2022 New Esophageal Cancer Tests on Horizon as Hopkins Spinout Capsulomics Preps Clinical Launch Premium Feb 25, 2022 CHMP Recommends Approval for Opdivo in PD-L1-Positive Esophageal, Urothelial Cancers Sep 17, 2021 CHMP Recommends BMS' Opdivo Plus Chemo for First-Line PD-L1-Positive Gastric Cancers Jul 13, 2021 Gastric Cancer Cases Frequently Harbor Genetic Risk Variants, Suggesting Germline Testing Jun 29, 2021 Merck's Keytruda Plus Chemo Approved in Europe for Certain Gastroesophageal Cancers Jun 6, 2021 BMS' Immunotherapy Combinations Improve Overall Survival in First-Line Esophageal Cancer Premium May 24, 2021 CHMP Recommends Merck's Keytruda Plus Chemo for Certain Esophageal, Gastroesophageal Cancers May 5, 2021 FDA Approves Keytruda-Herceptin Combination for HER2-Positive Gastric, Gastroesophageal Cancer Feb 18, 2021 Stella Diagnostics, Mayo Clinic Collaborating on Barrett's Esophagus Protein Markers Jan 4, 2021 EMA Accepts Bristol Myers Squibb's Submission for Opdivo in Gastroesophageal Cancers Oct 13, 2020 University of Minnesota, Intima Bioscience Begin Trial of CRISPR-Edited Cell Therapy for GI Cancer Oct 12, 2020 Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test Sep 22, 2020 Merck's Keytruda, BMS's Opdivo Prolong Survival for Patients With Gastroesophageal Cancers Premium Sep 8, 2020 Early Copy Number Changes Predict Progression of Barrett's Esophagus to Esophageal Cancer Jul 24, 2020 My Personal Therapeutics to Test Fruit Fly Avatar Technology in Gastrointestinal Cancer Patients Premium Jul 1, 2020 AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection Premium Apr 8, 2020 Esophageal Cancer Case Study Suggests Utility as Clinicians Explore Expanded Uses for Liquid Biopsy Premium Load More Breaking News European Commission Approves Libtayo in PD-L1-Positive Non-Small Cell Lung Cancer NICE Backs Merck's Keytruda for PD-L1-Expressing Cervical Cancer Genialis Closes $13M Series A Funding Round Breast Cancer Study Leads to New Susceptibility Gene, Potential Treatment Strategies Incyte's Pemazyre Approved in Japan for FGFR1-Positive Rare Blood Cancers Cardiff Oncology Begins Phase II Onvansertib Trial in KRAS-, NRAS-Mutant Colorectal Cancer
